Clinigen divests global rights to four cancer support therapies to CNX Therapeutics
August 10, 2023 09:46 ET
|
Clinigen
10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the...